Insider & Political Trading

Official filings, normalized for faster research

Previous-day view · Mon Sep 14 close. You are previewing the previous trading day. Subscribe to see today live and every other date — plans start at Delta, $39/mo. Sign up Sign in

Desk brief

AI Sep 14

The tape was heavily sell-skewed: 473 filings reported about $154.2M bought versus $745.9M sold, with only one congressional disclosure.

Two insider buying clusters — Cluster buying led the notable signals: four insiders bought roughly $671.5K of PMTS across four filers, while four bought about $992.1K of GPUS across four filers. PMTS GPUS

Multiple insider selling clusters — Selling clusters were broader and larger, including five insiders selling about $18.6M of CHYM, four selling $17.4M of DBX, seven selling $9.2M of COST, three selling $2.1M of IOT, and 11 selling $2.2M of LOGI. CHYM DBX COST IOT LOGI

Cascade added heavily to RSG — Cascade Investment, L.l.c. bought roughly $453.0M of RSG and was also flagged as a 10% owner adding about $453.4M. RSG was the most bought ticker over 14 days at about $695.1M from one filer. RSG L.l.c. Cascade Investment

Largest reported purchase — Over the past 14 days, Bluearc Capital Management, Llc reported the largest purchase at roughly $99.4M of PBLSX. The broader period remained sell-heavy, with about $1.4B bought versus $13.0B sold. PBLSX Llc Bluearc Capital Management

The filings to keep on the tape were the four-filer buying clusters in PMTS and GPUS versus the larger insider selling clusters in CHYM, DBX, COST, IOT, and LOGI. YPF remained the most sold ticker over 14 days at about $5.3B across 22 filers, followed by APGE at about $1.1B across nine filers.

AI-generated from the filings on this page — not financial advice.

Filings · Sep 14

1039

Latest about 17 hours ago

Disclosed buying · 14d

$1.37B

1086 purchases across 1465 tickers

Disclosed selling · 14d

$12.97B

6077 sales and dispositions

Tape lean · 14d

Heavy selling

Largest buy: PBLSX $99.38M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings

Most bought

Most sold

Signals

Fixed rules over the last 21 days — see each card for why it fired

Cluster selling CHYM

7 insiders sold $209.03M about 17 hours ago

Cluster selling PMTS

9 insiders sold $55.22M about 18 hours ago

Cluster selling DK

9 insiders sold $3.34M about 18 hours ago

Cluster selling ROIV

7 insiders sold $9.26M about 18 hours ago

Cluster selling PCOR

5 insiders sold $8.15M about 19 hours ago

Cluster selling THC

4 insiders sold $37.02M about 19 hours ago

Cluster buying PMTS

5 insiders bought $11.96M about 19 hours ago

$1M+ insider buy PMTS

Tricor Pmt25 Holdings Inc. bought $11.29M about 19 hours ago

10% owner adding PMTS

Tricor Pmt25 Holdings Inc. added $11.29M about 19 hours ago

Executive buy DVN

Gaspar Clay M bought $199.88K about 20 hours ago

Cluster buying GPUS

4 insiders bought $1.14M about 20 hours ago

Cluster selling FIGR

3 insiders sold $20.39M about 20 hours ago

Disclosure sentiment

Who is buying against who is selling · 90 days · −100 to +100

Accumulation

AMR 26 buys · 0 sells +100

AAT 17 buys · 0 sells +100

RCG 52 buys · 0 sells +100

SUJA 22 buys · 0 sells +100

DLHC 43 buys · 0 sells +100

UUU 32 buys · 0 sells +100

Distribution

UTHR 0 buys · 496 sells -100

CRWV 0 buys · 785 sells -100

DELL 0 buys · 651 sells -100

SE 0 buys · 468 sells -100

NET 0 buys · 277 sells -100

STX 0 buys · 240 sells -100

Bullish and bearish sectors

Net disclosed value · 30 days

Buying extends right, selling left. A company in more than one industry counts in each.

642 filings

Official insider and political disclosure transactions
Filed	Transaction	Issuer / asset	Reporting person	Qty / price	Value	Source
Aug 19, 2026 3-day lag	Sale Aug 17, 2026	ADPT Adaptive Biotechnologies Corp Common Stock	Robins Chad M Insider CEO And Chairman	318,799 shares @ $25.08 Direct ownership	$8M	SEC Form 4
Same filing as the row above	Exercise Aug 17, 2026 Stock Option (right to buy) on Common Stock			321,324 shares @ $0 Direct ownership	$0
Aug 19, 2026 3-day lag	Sale Aug 17, 2026	ADPT Adaptive Biotechnologies Corp Common Stock	Neupert Peter M Insider Director	69,690 shares @ $25.16 Direct ownership	$1.75M	SEC Form 4
Same filing as the row above	Sale Aug 17, 2026			40,000 shares @ $25.1 Direct ownership	$1M
Same filing as the row above	Exercise Aug 17, 2026			15,000 shares @ $6.32 Direct ownership	$94.8K
Same filing as the row above	Exercise Aug 17, 2026 Stock Option (right to buy) on Common Stock			15,000 shares @ $0 Direct ownership	$0
Same filing as the row above	Sale Aug 17, 2026 Common Stock			15,000 shares @ $25.23 Direct ownership	$378.45K
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Non-Qualified Stock Options (right to buy) on...	Peoples George Insider Director	4,000 shares @ $0 Direct ownership	$0	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Non-Qualified Stock Options (right to buy) on...	Leftwich Scott Insider Director	4,000 shares @ $0 Direct ownership	$0	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Non-Qualified Stock Options (right to buy) on...	Stewart Alan R. Insider Director	4,000 shares @ $0 Direct ownership	$0	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Stock Options (right to buy) on Common stock	Jackson Andrew C. Insider Chief Financial Officer	14,000 shares Direct ownership	Not reported	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Non-Qualified Stock Options (right to buy) on...	Schoeneck James A Insider Director	5,000 shares @ $0 Direct ownership	$0	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Stock Options (right to buy) on Common stock	Poma Eric E Insider Chief Executive Officer	32,000 shares Direct ownership	Not reported	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Stock Options (right to buy) on Common stock	Fernandez Santidrian Antonio Insider Chief Scientific Officer	16,000 shares Direct ownership	Not reported	SEC Form 4
Aug 19, 2026 2-day lag	Award Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc. Non-Qualified Stock Options (right to buy) on...	Sanders Corazon (corsee) D. Insider Director	6,000 shares @ $0 Direct ownership	$0	SEC Form 4
Aug 19, 2026 2-day lag	Disposition Aug 17, 2026	MAR Marriott International Inc /md/ Class A Common - Restricted Stock Units	Jones Neal Insider President, Emea	107 shares @ $355.49 Direct ownership	$38.04K	SEC Form 4
Aug 19, 2026 2-day lag	Exercise Aug 17, 2026	PTCT Ptc Therapeutics, Inc. Stock Option (Right to Buy) on Common Stock	Boulding Mark Elliott Insider Exec. VP And CLO	2,813 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Sale Aug 17, 2026 Common Stock			969 shares @ $72.9 Direct ownership	$70.64K
Same filing as the row above	Sale Aug 17, 2026			1,844 shares @ $72.39 Direct ownership	$133.49K
Same filing as the row above	Exercise Aug 17, 2026			2,813 shares @ $25.69 Direct ownership	$72.27K
Aug 19, 2026 2-day lag	Exercise Aug 17, 2026	ARQT Arcutis Biotherapeutics, Inc. Common Stock	Welgus Howard G. Insider Director	1,019 shares @ $7.51 Direct ownership	$7.65K	SEC Form 4
Same filing as the row above	Exercise Aug 17, 2026 Stock Option (right to buy) on Common Stock			822 shares @ $0 Direct ownership	$0
Same filing as the row above	Exercise Aug 17, 2026			1,019 shares @ $0 Direct ownership	$0
Same filing as the row above	Sale Aug 17, 2026 Common Stock			4,730 shares @ $26.18 Direct ownership	$123.83K
Same filing as the row above	Exercise Aug 17, 2026 Stock Option (right to buy) on Common Stock			2,255 shares @ $0 Direct ownership	$0